selectION Therapeutics has filed a notice of an exempt offering of securities to raise $11,809,601.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, selectION Therapeutics is raising $11,809,601.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Steve Zaniboni played a key role…